Related Experiment Videos
Paracetamol efficacy and safety in children: the first 40 years
1Clinical pharmacologist, Royal Children's Hospital, Parkville, Victoria, 3052, Australia.
Insights
Paracetamol (acetaminophen) is the leading choice for managing fever and pain in children due to its safety and efficacy. While generally safe, overdose can cause liver damage, necessitating prompt treatment.
Area of Science:
- Pediatric Pharmacology
- Pain Management
- Fever Treatment
Background:
- Paracetamol (acetaminophen) is a widely used medication for children's fever and pain.
- It is considered safe and well-tolerated at recommended pediatric doses.
- Fever alone doesn't require treatment, but paracetamol alleviates associated discomfort and pain.
Purpose of the Study:
- To review the role and dosing of paracetamol in pediatric pain and fever management.
- To discuss the safety profile, including overdose risks and management.
- To compare paracetamol with other analgesics/antipyretics like aspirin and ibuprofen.
Main Methods:
- Literature review of pediatric dosing guidelines for paracetamol.
- Analysis of paracetamol's efficacy in mild, moderate, and severe pain.
- Examination of overdose toxicity, antidotes, and monitoring tools (Rumack-Matthew Nomogram).
Main Results:
- Pediatric paracetamol dosing ranges globally from 10-15 mg/kg every 4 hours.
- It provides effective analgesia and antipyresis, with additive effects in severe pain.
- Overdose (>10x recommended dose) is hepatotoxic; early treatment is effective. Chronic overdose risk exists above 140 mg/kg/day.
- Aspirin use has declined; ibuprofen is a second-line option.
Conclusions:
- Paracetamol remains the first-line treatment for pediatric analgesia and antipyresis.
- Appropriate dosing is crucial to maximize efficacy and minimize hepatotoxicity risks.
- Effective antidotes and nomograms improve overdose management outcomes in children.
Abstract:
Paracetamol (acetaminophen) has a unique role in children because it is the first-line choice for the treatment of both fever and pain. When used in the recommended doses, it has few side effects and is remarkably well tolerated. While fever alone requires no treatment, when associated with discomfort or pain, paracetamol offers relief. Also, for mild to moderate pain, paracetamol, either alone or in combination with another drug, is effective. Even in severe pain, paracetamol offers a significant additive analgesic effect to opiates. Globally, the pediatric dose varies between 10 and 15 mg/kg. In the United Kingdom, 10 mg/kg is given every 4 hours, up to a maximum of four doses per day; in Australia, 15 mg/kg is administered 4-hourly up to a total dose of 60 mg/kg/day. In overdose, paracetamol is hepatotoxic. Single ingestions of more than ten times the recommended dose are potentially toxic. The development of specific antidotes and the universal availability of the Rumack-Matthew Nomogram have made the early treatment of overdose effective without long-term sequelae. There are sporadic case reports of chronic overdosing resulting in liver failure. Although the specific predictors are still being defined, exposures greater than 140 mg/kg/day for several days carry a risk of serious toxicity. In children, aspirin use has almost disappeared with the concurrent decline in Reye Syndrome. Less clinical experience has accumulated with ibuprofen, and it remains the second-line treatment for fever and pain. In conclusion, paracetamol remains the first-choice over-the-counter treatment for analgesia and antipyresis in children.